BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

889 related articles for article (PubMed ID: 31130475)

  • 1. MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma.
    Li Y; Guan B; Liu J; Zhang Z; He S; Zhan Y; Su B; Han H; Zhang X; Wang B; Li X; Zhou L; Zhao W
    EBioMedicine; 2019 Jun; 44():439-451. PubMed ID: 31130475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma.
    Cui L; Zhou H; Zhao H; Zhou Y; Xu R; Xu X; Zheng L; Xue Z; Xia W; Zhang B; Ding T; Cao Y; Tian Z; Shi Q; He X
    BMC Cancer; 2012 Nov; 12():546. PubMed ID: 23173671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
    Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L
    J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-1293 Suppresses Tumor Malignancy by Targeting Hydrocyanic Oxidase 2: Therapeutic Potential of a miR-1293/Hydrocyanic Oxidase 2 Axis in Renal Cell Carcinoma.
    Liu XL; Pan WG; Li KL; Mao YJ; Liu SD; Zhang RM
    Cancer Biother Radiopharm; 2020 Jun; 35(5):377-386. PubMed ID: 31971830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sunitinib-suppressed miR-452-5p facilitates renal cancer cell invasion and metastasis through modulating SMAD4/SMAD7 signals.
    Zhai W; Li S; Zhang J; Chen Y; Ma J; Kong W; Gong D; Zheng J; Xue W; Xu Y
    Mol Cancer; 2018 Nov; 17(1):157. PubMed ID: 30419914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-22 functions as a tumor suppressor by targeting SIRT1 in renal cell carcinoma.
    Zhang S; Zhang D; Yi C; Wang Y; Wang H; Wang J
    Oncol Rep; 2016 Jan; 35(1):559-67. PubMed ID: 26499759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-186 Suppresses Cell Proliferation and Metastasis Through Targeting Sentrin-Specific Protease 1 in Renal Cell Carcinoma.
    Jiao D; Wu M; Ji L; Liu F; Liu Y
    Oncol Res; 2018 Mar; 26(2):249-259. PubMed ID: 28550686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-206 inhibits renal cell cancer growth by targeting GAK.
    Wei C; Wang S; Ye ZQ; Chen ZQ
    J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):852-858. PubMed ID: 27924503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CircTLK1 promotes the proliferation and metastasis of renal cell carcinoma by sponging miR-136-5p.
    Li J; Huang C; Zou Y; Ye J; Yu J; Gui Y
    Mol Cancer; 2020 Jun; 19(1):103. PubMed ID: 32503552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-376a functions as tumor suppressor by targeting SGK3 in renal cell carcinoma.
    Fan XR; Zhang ZY; Wang RH; Li Y; Mao QZ
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3726-3732. PubMed ID: 31114998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-28-5p acts as a tumor suppressor in renal cell carcinoma for multiple antitumor effects by targeting RAP1B.
    Wang C; Wu C; Yang Q; Ding M; Zhong J; Zhang CY; Ge J; Wang J; Zhang C
    Oncotarget; 2016 Nov; 7(45):73888-73902. PubMed ID: 27729617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-203 inhibition of renal cancer cell proliferation, migration and invasion by targeting of FGF2.
    Xu M; Gu M; Zhang K; Zhou J; Wang Z; Da J
    Diagn Pathol; 2015 Apr; 10():24. PubMed ID: 25890121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA ZFPM2-AS1 promotes the tumorigenesis of renal cell cancer via targeting miR-137.
    Liu JG; Wang HB; Wan G; Yang MZ; Jiang XJ; Yang JY
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5675-5681. PubMed ID: 31298319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The miR-200 family as prognostic markers in clear cell renal cell carcinoma.
    Saleeb R; Kim SS; Ding Q; Scorilas A; Lin S; Khella HW; Boulos C; Ibrahim G; Yousef GM
    Urol Oncol; 2019 Dec; 37(12):955-963. PubMed ID: 31635993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor PDCD4 and promotes cell transformation, proliferation, and metastasis in renal cell carcinoma.
    Li X; Xin S; He Z; Che X; Wang J; Xiao X; Chen J; Song X
    Cell Physiol Biochem; 2014; 33(6):1631-42. PubMed ID: 24902663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-129-3p, as a diagnostic and prognostic biomarker for renal cell carcinoma, attenuates cell migration and invasion via downregulating multiple metastasis-related genes.
    Chen X; Ruan A; Wang X; Han W; Wang R; Lou N; Ruan H; Qiu B; Yang H; Zhang X
    J Cancer Res Clin Oncol; 2014 Aug; 140(8):1295-304. PubMed ID: 24802708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-30a-5p Inhibits the Growth of Renal Cell Carcinoma by Modulating GRP78 Expression.
    Wang C; Cai L; Liu J; Wang G; Li H; Wang X; Xu W; Ren M; Feng L; Liu P; Zhang C
    Cell Physiol Biochem; 2017; 43(6):2405-2419. PubMed ID: 29073630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of microRNA-15a suppresses the proliferation and invasion of renal cell carcinoma via direct targeting of eIF4E.
    Li G; Chong T; Xiang X; Yang J; Li H
    Oncol Rep; 2017 Oct; 38(4):1995-2002. PubMed ID: 28849086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-33a inhibits cell growth in renal cancer by downregulation of MDM4 expression.
    Jiang K; Sun F; Zhu J; Luo G; Ban Y; Zhang P
    Mol Genet Genomic Med; 2019 Aug; 7(8):e833. PubMed ID: 31250570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ciRS-7 is a prognostic biomarker and potential gene therapy target for renal cell carcinoma.
    Mao W; Wang K; Xu B; Zhang H; Sun S; Hu Q; Zhang L; Liu C; Chen S; Wu J; Chen M; Li W; Peng B
    Mol Cancer; 2021 Nov; 20(1):142. PubMed ID: 34740354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.